Details

Autor(en) / Beteiligte

• Lopez-Herdoiza, Maria-Belen
• Bauché, Stephanie
• Wilmet, Baptiste
• Le Duigou, Caroline
• Roussel, Delphine
• Frah, Magali
• Béal, Jonas
• Devely, Gabin
• Boluda, Susana
• Frick, Petra
• Bouteiller, Delphine
• Dussaud, Sébastien
• Guillabert, Pierre
• Dalle, Carine
• Dumont, Magali
• Camuzat, Agnes
• Saracino, Dario
• Barbier, Mathieu
• Bruneteau, Gaelle
• Ravassard, Phillippe
• Neumann, Manuela
• Nicole, Sophie
• Le Ber, Isabelle
• Brice, Alexis
• Latouche, Morwena

Titel

C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice

Ist Teil von

• Frontiers in cellular neuroscience, 2023-04, Vol.17, p.1155929-1155929

Ort / Verlag

Switzerland: Frontiers Research Foundation

Erscheinungsjahr

2023

Link zum Volltext

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• The GGGGCC intronic repeat expansion within is the most common genetic cause of ALS and FTD. This mutation results in toxic gain of function through accumulation of expanded RNA foci and aggregation of abnormally translated dipeptide repeat proteins, as well as loss of function due to impaired transcription of . A number of and models of gain and loss of function effects have suggested that both mechanisms synergize to cause the disease. However, the contribution of the loss of function mechanism remains poorly understood. We have generated C9ORF72 knockdown mice to mimic C9-FTD/ALS patients haploinsufficiency and investigate the role of this loss of function in the pathogenesis. We found that decreasing C9ORF72 leads to anomalies of the autophagy/lysosomal pathway, cytoplasmic accumulation of TDP-43 and decreased synaptic density in the cortex. Knockdown mice also developed FTD-like behavioral deficits and mild motor phenotypes at a later stage. These findings show that C9ORF72 partial loss of function contributes to the damaging events leading to C9-FTD/ALS.